Skip to main content
. 2021 Jan 27;8:629835. doi: 10.3389/fchem.2020.629835

FIGURE 10.

FIGURE 10

Comparison of the toxicity response of CuHARS and anti-cancer drug Doxorubicin (DOX), against glioma cells CRL2303, plated at 5,000 (5k) or 10,000 (10k) cells/well. Viability was calculated using MTT assay as described in methods, and data were normalized to control values, which were set to 100%. Data represent average over three experiments (N = 3) with triplicated wells (n = 3). The error bars represent SEM values.